(Q33985009)

30 July 2017

1 reference

title

Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs (English)

1 reference

30 July 2017

1 reference

Reddy BS

1

1 reference

PubMed ID

10917070

30 July 2017

Rao CV

series ordinal

2

1 reference

30 July 2017

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

5

1 reference

30 July 2017

329-334

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200016050-00002

30 July 2017

0 references

cites work

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

12 December 2020

Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

1 reference

12 December 2020

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

1 reference

12 December 2020

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

1 reference

12 December 2020

Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.

1 reference

12 December 2020

The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention

1 reference

12 December 2020

Eicosanoids and the gastrointestinal tract

1 reference

12 December 2020

Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds

1 reference

12 December 2020

Sulindac for polyposis of the colon.

1 reference

12 December 2020

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

12 December 2020

Vegetables, fruit and phytoestrogens as preventive agents.

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

12 December 2020

1 reference

12 December 2020

Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

1 reference

12 December 2020

Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

1 reference

12 December 2020

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

1 reference

12 December 2020

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

12 December 2020

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

12 December 2020

Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea

1 reference

12 December 2020

Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam

1 reference

12 December 2020

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

12 December 2020

Prospects for preventing colorectal cancer death

1 reference

12 December 2020

Perspectives on cancer chemoprevention research and drug development.

1 reference

12 December 2020

Aspirin and the potential role of prostaglandins in colon cancer

1 reference

12 December 2020

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

12 December 2020

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

12 December 2020

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

12 December 2020

Aspirin use and reduced risk of fatal colon cancer

1 reference

12 December 2020

Chemoprevention of cancer

1 reference

12 December 2020

Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis

1 reference

12 December 2020

10.2165/00002512-200016050-00002

Identifiers

DOI

1 reference

PubMed ID

10917070

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10917070